We are Sorry, This Page doesn't Exist

Shares of Gilead Sciences Inc.'s stock gained 2.1% in after-hours trading on Thursday after the drug maker surprised investors with better-than-expected sales of its COVID-19 drug Veklury during the fourth quarter of 2020......»»

Arcus Biosciences Inc. disclosed Monday that Gilead Sciences Inc. boosted its stake in the oncology-focused biopharmaceutical company, through the purchase of $220.35 million worth of stock. Arcus shares were still inactive in pr.....»»

Stock Options Channel.....»»

Tao Value recently released its Q1 2020 Investor Letter, a copy of which you can download here. The fund posted a return of -12.96% for t.....»»

Shares of Gilead Sciences Inc. were down 5.9% in trading on Friday after at least three analysts downgraded the stock, citing a range of concerns. R.....»»

Stock Options Channel.....»»

InvestorPlace - Stock Market .....»»

Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»

Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»

Investors who owned stocks in the 2010s generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return for the decade was 250.5%. But there’s no question some big-name stocks did much better than others along the way. read more.....»»

U.S. stock benchmarks added to strong gains Wednesday afternoon after Dr. Anthony Fauci described data from a drug trial of Gilead Sciences' remdesivir showed "quite good news," in treating certain patients stricken with the illness from th.....»»

Gilead Sciences, Inc. (NASDAQ: GILD) .....»»

U.S. stock index futures jumped on Wednesday after Gilead Sciences said its experimental antiviral drug met the main goal of a trial testing it in COVID-19 patients......»»

Gilead Sciences Inc. said Wednesday morning that a government-run clinical trial evaluating its experimental drug remdesivir in certain COVID-19 patie.....»»

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Late last week, a Financial Times report suggested that Gilead’s cor.....»»

InvestorPlace - Stock Market News, Stock Advice & .....»»

Gilead Sciences, Inc. (NASDAQ: GILD) shares were trading lower Thursday after the Financial Times reported that the company ended a study on remdesivir in coronavirus in China due to low enrollment an read more.....»»

Shares of Gilead Sciences Inc. were down 5.3% in trading on Thursday after a Stat News report said a draft of the clinical trial results for remdesivir, an experimental drug being tested as a treatment for COVID-19, showed that the drug did not spe.....»»

Shares of Gilead Sciences Inc. gained 0.4% in trading on Monday after BMO Capital Markets downgraded the stock to market perform from outperform. Analysts there believe that despite [l: investor excitement about remdesivir, an experimental drug being .....»»

Gilead Sciences, Inc. (NASDAQ: GILD) surged more than 16% after hours Thursday when STAT News reported promising preliminary results for a prospective COVID-19 thera Late.....»»